Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit will shine a spotlight on optimizing the selectivity and tolerability of your anti-RAS therapies, exploring novel combination strategies and overcome translational pharmacology challenges to set the stage for the 2nd generation of mutation-targeted RAS modulating therapies yet to come.
Event stats:
42+ world class speakers, 36+ late-breaking case studies, 2 dedicated streams, 6+ technical workshops, 250 + senior attendees And 8+ hours off dedicated networking
Take advantage of our group discounts, academic rates and earlybird savings - don't miss out register now for the best rate!
Event stats:
42+ world class speakers, 36+ late-breaking case studies, 2 dedicated streams, 6+ technical workshops, 250 + senior attendees And 8+ hours off dedicated networking
Take advantage of our group discounts, academic rates and earlybird savings - don't miss out register now for the best rate!
